Maitake mushroom (Grifola frondosa): Systematic review by the natural standard research collaboration

Journal of the Society for Integrative Oncology

Volumn 7, Issue 2, 2009, Pages 66-72

  Ulbricht, Catherine ^a,b   Weissner, Wendy ^b   Basch, Ethan ^c   Giese, Nicole ^b   Hammerness, Paul ^d   Rusie Seamon, Erica ^e   Varghese, Minney ^f   Woods, Jen ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Natural Standard   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NOVA SOUTHEASTERN UNIVERSITY   (United States)

^f NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Beta glucan; Grifola frondosa; Herbs and supplements; Interactions; Maitake; Pharmacology; Systematic review

Indexed keywords

ALPHA INTERFERON; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; GAMMA INTERFERON; GRIFOLA FRONDOSA EXTRACT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 4; MITOMYCIN C; NATURAL PRODUCT; UNCLASSIFIED DRUG; BETA GLUCAN; IMMUNOLOGICAL ADJUVANT;

ALLERGIC PNEUMONITIS; ARTHRITIS; BACTERIAL INFECTION; BIBLIOGRAPHIC DATABASE; BONE CANCER; BREAST CANCER; CELL STRAIN HEPG2; CHICKENPOX; CHINESE MEDICINE; CYTOKINE PRODUCTION; DIABETES MELLITUS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESEARCH; DRUG SAFETY; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FOOD DRUG INTERACTION; GRIFOLA; GRIFOLA FRONDOSA; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSTIMULATION; LABORATORY TEST; LACTATION; LEUKEMIA; LIVER CANCER; LUNG CANCER; MEDICAL LITERATURE; MUSHROOM; MYCOSIS; NONHUMAN; PREGNANCY; REVIEW; SNAKEBITE; STOMACH CANCER; SYSTEMATIC REVIEW; TRADITIONAL MEDICINE; TUMOR REGRESSION; VERRUCA VULGARIS; VIRUS INFECTION; ANIMAL; CHEMISTRY; NEOPLASM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BETA-GLUCANS; DIABETES MELLITUS; FOOD-DRUG INTERACTIONS; GRIFOLA; HUMANS; NEOPLASMS;

EID: 67649406298     PISSN: 1715894X     EISSN: None     Source Type: Journal    
DOI: 10.2310/7200.2009.0007     Document Type: Review

References (50)

1. Mori K, Toyomatsu T, Nanba H, Kuroda H. Antitumor activities of edible mushrooms by oral administration. Presented at the International Symposium, Scientific and Technical Aspects of Cultivating Edible Fungi. Pennsylvania State University, University Park, PA; 1986.
2. Hishida I, Nanba H, Kuroda H. Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (maitake). Chem Pharm Bull (Tokyo) 1988;36:1819-27.
3. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
4. Tanaka H, Tsunematsu K, Nakamura N, et al. Successful treatment of hypersensitivity pneumonitis caused by Grifola frondosa (maitake) mushroom using a HFA-BDP extra-fine aerosol. Intern Med 2004;43:737-40.
5. Kabir Y, Yamaguchi M, Kimura S. Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. J Nutr Sci Vitaminol. (Tokyo) 1987;33:341-6.
6. Kabir Y, Kimura S. Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol (Tokyo) 1989;35:91-4.
7. Kubo K, Aoki H, Nanba H. Anti-diabetic activity present in the fruit body of Grifola frondosa (maitake). I. Biol Pharm Bull 1994;17:1106-10.
8. Manohar V, Talpur NA, Echard BW, et al. Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes Metab 2002;4:43-8.
9. Horio H, Ohtsuru M. Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats. J Nutr Sci Vitaminol (Tokyo) 2001;47:57-63.
10. Konno S, Tortorelis DG, Fullerton SA, et al. A possible hypoglycaemic effect of maitake mushroom on type 2 diabetic patients. Diabet Med 2001;18:1010.
11. Hong L, Xun M, Wutong W. Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice. J Pharm Pharmacol 2007; 59:575-82.
12. Preuss HG, Echard B, Bagchi D, et al. Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom. Mol Cell Biochem 2007;306:105-13.
13. Nanba H. Maitake D-fraction: healing and preventing potentials for cancer. Townsend Lett Doctors Patients 1996;151/152:84-5.
14. Tazaki H, Konno S, Fullerton S, Samadi A. Apoptosis in prostatic cancer cells with maitake D-fraction extract: potential alternative therapy. Townsend Lett Doctors Patients 2001;217/218:100.
15. Ohno N, Suzuki I, Oikawa S, et al. Antitumor activity and structural characterization of glucans extracted from cultured fruit bodies of Grifola frondosa. Chem Pharm Bull (Tokyo) 1984;32:1142-51.
16. Ohno N, Egawa Y, Hashimoto T, et al. Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol Pharm Bull 1996; 19:608-12.
17. Sanzen I, Imanishi N, Takamatsu N, et al. Nitric oxide-mediated antitumor activity induced by the extract from Grifola frondosa (maitake mushroom) in a macrophage cell line, RAW264.7. J Exp Clin Cancer Res 2001;20:591-7.
18. Gu CQ, Li JW, Chao F, et al. Isolation, identification and function of a novel anti-HSV-1 protein from Grifola frondosa. Antiviral Res 2007;75:250-7.
19. Gu CQ, Li J, Chao FH. Inhibition of hepatitis B virus by D-fraction from Grifola frondosa: synergistic effect of combination with interferon-alpha in HepG2 2.2.15. Antiviral Res 2006;72:162-5.
20. Inoue A, Kodama N, Nanba H. Effect of maitake (grifolafrondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull 2002;25:536-40.
21. Spelman K, Burns J, Nichols D, et al. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 2006;11:128-50.
22. Wu MJ, Cheng TL, Cheng SY, et al. Immunomodulatory properties of Grifola frondosa in submerged culture. J Agric Food Chem 2006;54:2906-14.
23. Yang BK, Gu YA, Jeong YT, et al. Chemical characteristics and immuno-modulating activities of exobiopolymers produced by Grifola frondosa during submerged fermentation process. Int J Biol Macromol 2007;41:227-33.
24. Adachi K, Nanba H, Kuroda H. Potentiation of host-mediated antitumor activity in mice by beta-glucan obtained from Grifola frondosa (maitake). Chem Pharm Bull (Tokyo) 1987;35:262-70.
25. Li X, Rong J, Wu M, Zeng X. [Anti-tumor effect of polysaccharide from Grifola frondosa and its influence on immunological function]. Zhong Yao Cai 2003;26:31-2.
26. Konno S. Potential growth inhibitory effect of maitake D-fraction on canine cancer cells. Vet Ther 2004;5:263-71.
27. Lin H, Cheung SW, Nesin M, et al. Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production. Clin Vaccine Immunol 2007;14:21-7.
28. Matsui K, Kodama N, Nanba H. Effects of maitake (Grifola frondosa) D-fraction on the carcinoma angiogenesis. Cancer Lett 2001;172:193-8.
29. Nanba H, Hamaguchi A, Kuroda H. The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chem Pharm Bull 1987;34:1162-8.
30. Nanba H. Antitumor activity of orally administered "D-fraction" from maitake mushroom (Grifola frondosa)/ J Naturopath Med 1993;4:10-5.
31. Griessmayr PC, Gauthier M, Barber LG, Cotter SM. Mushroom-derived maitake PETfraction as single agent for the treatment of lymphoma in dogs. J Vet Intern Med 2007;21:1409-12.
32. Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull 1994;17:1554-60.
33. Adachi Y, Ohno N, Yadomae T. Activation of murine kupffer cells by administration with gel-forming (1-->3)-beta-D-glucan from Grifola frondosa. Biol Pharm Bull 1998;21:278-83.
34. Cui FJ, Li Y, Xu YY, et al. Induction of apoptosis in SGC?7901 cells by polysaccharide-peptide GFPS1b from the cultured mycelia of Grifola frondosa GF9801. Toxicol In Vitro 2007;21:417-27.
35. Fullerton SA, Samadi AA, Tortorelis DG, et al. Induction of apoptosis in human prostatic cancer cells with beta-glucan (maitake mushroom polysaccharide). Mol Urol 2007;4:7-13.
36. Ishibashi K, Miura NN, Adachi Y, et al. Relationship between solubility of grifolan, a fungal 1,3-beta-D-glucan, and production of tumor necrosis factor by macrophages in vitro. Biosci Biotechnol Biochem 2001;65:1993-2000.
37. Lin JT, Liu WH. o-Orsellinaldehyde from the submerged culture of the edible mushroom Grifola frondosa exhibits selective cytotoxic effect against Hep 3B cells through apoptosis. J Agric Food Chem 2006;54:7564-9.
38. Okazaki M, Adachi Y, Ohno N, Yadomae T. Structureactivity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro. Biol Pharm Bull 1995;18:1320-7.
39. Suzuki I, Itani T, Ohno N, et al. Antitumor activity of a polysaccharide fraction extracted from cultured fruiting bodies of Grifola frondosa. J Pharmacobiodyn 1984;7:492-500.
40. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Altern Med Rev 2002;7:236-9.
41. Borchers AT, Stern JS, Hackman RM, et al. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med1999; 221:281-93.
42. Chang R. Functional properties of edible mushrooms. Nutr Rev 1996;54:S91-3.
43. Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 2000;5:4-27.
44. Mayell M. Maitake extracts and their therapeutic potential. Altern Med Rev 2001;6:48-60.
45. Sliva D. Cellular and physiological effects of Ganoderma lucidum (reishi). Mini Rev Med Chem 2004;4:873-9.
46. Shigesue K, Kodama N, Nanba H. Effects of maitake (Grifola frondosa) polysaccharide on collageninduced arthritis in mice. Jpn J Pharmacol 2000; 84:293-300.
47. Kodama N, Yamada M, Nanba H. Addition of maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn J Pharmacol 2001;87:327-32.
48. Kubo K, Nanba H. The effect of maitake mushrooms on liver and serum lipids. Altern Ther Health Med 1996;2:62-6.
49. Fukushima M, Ohashi T, Fujiwara Y, et al. Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Exp Biol Med (Maywood) 2001;226:758-65.
50. Kubo K, Nanba H. Anti-hyperliposis effect of maitake fruit body (Grifola frondosa). I. Biol Pharm Bull 1997;20:781-5.